بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant risks » significant risk (توسيع البحث), significant results (توسيع البحث), significant role (توسيع البحث)
risks decrease » sizes decrease (توسيع البحث), visits decreased (توسيع البحث), rivers decreased (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant risks » significant risk (توسيع البحث), significant results (توسيع البحث), significant role (توسيع البحث)
risks decrease » sizes decrease (توسيع البحث), visits decreased (توسيع البحث), rivers decreased (توسيع البحث)
-
81
Pie charts showing the different patterns of risk factors associated with total colony losses.
منشور في 2025الموضوعات: -
82
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin...
منشور في 2025"…<p dir="ltr">HIV acquisition risk with norethisterone (NET) enanthate (NET-EN) is reportedly less than for depo-medroxyprogesterone acetate intramuscular (DMPA-IM). …"
-
83
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
84
-
85
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
86
-
87
-
88
-
89
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
90
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
91
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: -
92
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
93
-
94
-
95
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
منشور في 2025الموضوعات: -
96
-
97
Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
منشور في 2025"…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…"
-
98
Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
منشور في 2025"…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…"
-
99
Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
منشور في 2025"…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…"
-
100
Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
منشور في 2025"…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…"